Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.36.8NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.243NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.243NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
R.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
R.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
W.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
W.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.565NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.565NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.361NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.361NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.101NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.101NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.478NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.478NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.177.86NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.86NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.543NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.543NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.139NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.139NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
C.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.31NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.221NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.221NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.362NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.362NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.265NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.265NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.518NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.518NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.551NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.551NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
C.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.17NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.207NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.207NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.604NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.604NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.111NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.111NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.619NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.619NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
C.36.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.36.3.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
C.36.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.36.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
A.23.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used